MRTX · Mirati Therapeutics
Acquired Company
Bristol Myers Squibb completed its acquisition of Mirati Therapeutics on January 23, 2024.
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops candidate products to address the genetic and immunological promoters of cancer in the United States. The company is headquartered in San Diego, California.
3545 CRAY COURT, SAN DIEGO, CA, UNITED STATES, 92121, California, 92121-3070, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
4.118B
52 Wk Range
$0.00 - $0.00
Previous Close
$58.70
Open
$58.70
Volume
N/A
Day Range
$58.70 - $58.70
Enterprise Value
N/A
Cash
258.7M
Avg Qtr Burn
-143.7M
Insider Ownership
1.72%
Institutional Own.
N/A
Qtr Updated
Sep 30th 2023